The world's first malaria vaccine is now available in certain areas of Kenya, offering an additional way to protect young children from this disease, which is a top 10 cause of illness and death, and a leading killer of children under the age of five....
-
MVI Portfolio
We strategically use our resources to support and advance a range of vaccine approaches that target both humoral and cellular immunity. -
Evaluation technology projects
We partner to develop and optimize new assays and challenge models and support reference and service laboratories. -
RTS,S
RTS,S/AS01 (RTS,S) is the world’s first malaria vaccine shown to provide partial protection against malaria in young children.
